2-Hydroxy Irinotecan-d10
| Product Name | 2-Hydroxy Irinotecan-d10 |
|---|---|
| Alternate Names | Irinotecan Stable Isotopes, Stable Isotopes of Irinotecan |
| CAT No. | CS-T-79404 |
| CAS No. | 1346597-30-5 |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Irinotecan |
| Smileys | CCC1=C2C=C(OC(N3CCC(N4C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C4([2H])[2H])CC3O)=O)C=CC2=NC5=C1CN6C5=CC7=C(COC(C7(O)CC)=O)C6=O |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
2-Hydroxy Irinotecan-d10 is a stable, deuterated form of the chemotherapy drug, Irinotecan. It is used in cancer treatment, particularly for colorectal cancer, as it is a topoisomerase inhibitor. The drug functions by inhibiting DNA replication and cell division, ultimately leading to the death of cancer cells.
The deuterated form of Irinotecan, 2-Hydroxy Irinotecan-d10, is used primarily in research studies and clinical trials. The addition of deuterium atoms to the drug molecule increases its stability and helps to improve the accuracy of the analysis of the drug's pharmacokinetics. This makes it easier to track the drug's effectiveness and determine optimal dosages.
The chemical structure of 2-Hydroxy Irinotecan-d10 is similar to that of the non-deuterated form, with the addition of ten deuterium atoms. The drug is administered intravenously and metabolized by the liver. The metabolites of 2-Hydroxy Irinotecan-d10 are excreted primarily through the feces, with a small amount eliminated through urine.
The use of 2-Hydroxy Irinotecan-d10 in cancer treatment is still being studied, and its efficacy and safety are not yet fully known. However, its use in research studies and clinical trials is crucial in the ongoing effort to develop more effective and targeted cancer treatments.
Get an Instant Quote
Related Compounds
Irinotecan D10 Hydrochloride |